How to Apply for Med-Tech Launcher Program 2026: TRL 7-9 Accelerator for Medical Devices

1. Online application and initial screening Applications go in through the portal at https://uppromotepharmacouncil.org/medtech-launcher. You will need detailed technical specifications of the innovation, your existing validation data, profiles of the core team, a clear statement of the market opportunity and a proposed regulatory strategy. The Program Management Unit (PMU) then screens submissions against the basic eligibility criteria, including the TRL band and product focus.

2. Detailed review and shortlisting Eligible applications go to a multi-disciplinary panel made up of MedTech specialists, clinicians from the identified institutions, regulatory affairs experts and business development professionals. Each is scored on clinical impact, technical maturity, market potential, regulatory feasibility, IP strength and team capabilities. Only high-potential innovations are shortlisted.

3. Interviews and due diligence Shortlisted teams are invited for in-depth interviews with the Apex Screening Board, chaired by the Managing Director of UP Promote Pharma Council, with representation from the Department of FSDA, NIPER Raebareli, CSIR-CDRI, NIB, IITs, and subject matter experts from the identified medical institutions and industry associations. Expect detailed technical and commercial discussion, an assessment of team dynamics and commitment, and verification of the claims made in your application. Clinical experts also weigh how readily the innovation can be integrated into real-world care settings.

4. Final selection Cumulative scores from the review and interview stages, along with panel consensus, decide the outcome. Priority goes to solutions with a clear pathway to addressing unmet clinical needs in Uttar Pradesh and a high probability of clearing clinical validation, regulatory approval and commercialisation.